Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioSante Pharmaceuticals, Inc. – Marketwatch
OKLAHOMA CITY, OK, Feb 07, 2012 (MARKETWIRE via COMTEX) -- On February 3, 2012, a class action lawsuit was ... violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including ...
Subscribe to LegalLaw247.Com Newsletter